U.S. Software Stock News

Embassy Bancorp (EMYB) has posted a clean set of Q3 2025 numbers, with total revenue of US$11.7 million and basic EPS of US$0.50, against a 12 month backdrop where revenue on a trailing basis moved from US$39.8 million to US$44.0 million and EPS from US$1.37 to US$1.68. The latest quarter sits within a year where earnings grew 21.3% versus the longer term trend and sets the stage for investors to focus on how a 29.1% net margin and a 2.58% net interest margin shape the quality and resilience...

In early March 2026, ACI Worldwide launched ACI Connetic for Cards, a next-generation, fully integrated, cloud-native card payments suite within its ACI Connetic platform, unifying account-to-account payments, card processing and AI-driven fraud prevention on a single enterprise-grade hub. This move gives banks and payment providers a modular way to modernize card operations and consolidate issuing, acquiring, ATM and fraud capabilities as global card transaction volumes keep expanding. Now...

Kaspi.kz (NasdaqGS:KSPI) has posted its FY 2025 results with Q4 revenue at KZT 1.1t and net income at KZT 276,983 million, translating into basic EPS of KZT 1,451.81, against a backdrop of trailing 12 month revenue of KZT 4.0t and net income of KZT 1,073,177 million. Over recent periods, the company has seen revenue move from KZT 744,178 million in Q4 2024 to KZT 1,146,548 million in Q4 2025, while quarterly basic EPS shifted from KZT 1,641.41 to KZT 1,451.81 and trailing basic EPS moved from...

Q2 Holdings (NYSE:QTWO) has seen a pattern of insider selling over the past year, with no insider share purchases reported in the same period. Most recently, General Counsel Michael Kerr sold company shares, adding to the ongoing insider selling trend. This activity comes as Q2 Holdings continues to operate as a provider of digital banking and financial experience software for banks and credit unions. Q2 Holdings focuses on cloud based digital banking platforms that help financial...

Black Diamond Therapeutics (BDTX) just posted a sharp swing into profit for FY 2025, with first half revenue of US$70 million translating to basic EPS of US$0.81, compared with losses in both halves of FY 2024. Over the past year, the company has seen revenue move from US$0 to US$70 million while basic EPS has shifted from losses of US$0.71 and US$0.56 in FY 2024 to a trailing 12 month figure of US$0.25. This sets up a results season where investors will focus squarely on how durable these...

Earlier this year, IDEXX Laboratories reported quarterly results that exceeded Wall Street expectations and raised its full-year guidance, underscoring robust demand for its veterinary diagnostic solutions and strength in pet healthcare. This performance highlights how IDEXX’s recurring revenue model and profitable diagnostics business can translate operational momentum into stronger earnings visibility. Next, we’ll examine how this earnings beat and upgraded guidance may reshape IDEXX’s...

Stoke Therapeutics (STOK) has reported FY 2025 results that feature a wide range of quarterly outcomes. Q1 revenue was US$158.6 million with EPS of US$1.95, followed by Q2 revenue of US$13.8 million and an EPS loss of US$0.40, and Q3 revenue of US$10.6 million with an EPS loss of US$0.65. Over recent periods the company has seen revenue move between US$4.8 million and US$158.6 million per quarter, while EPS has shifted from a US$2.07 loss in FY 2024 to a US$1.95 profit and then back into...

WW International (WW) has just posted its FY 2025 results with Q3 revenue of US$172.1 million and a basic EPS loss of US$1.04, set against a trailing 12 month net income of about US$1.1 billion that reflects a large one off gain. Over recent quarters the company has seen revenue move between US$184.4 million and US$202.1 million, while EPS has swung from a profit of US$0.31 to a loss of US$0.91 and then a very large profit of US$15.71. This pattern points to margins that appear to be heavily...

Earlier this week, Savers Value Village reported preliminary fourth-quarter results showing an 8.8% rise in U.S. comparable sales and 0.7% growth in Canada, while President and COO Jubran N. Tanious exercised options for 100,000 shares at US$1.41 and sold 45,000 shares for about US$373,644 on March 11, 2026. This combination of stronger U.S. store performance and fresh insider share activity offers investors new information on both operational momentum and executive incentives. We’ll now...

Q3 2026 snapshot: Value Line (VALU) leans on margins as earnings trends soften Value Line (VALU) has just reported its Q3 2026 results, with recent quarters showing revenue around US$8.6 million and basic EPS between US$0.42 and US$0.69, while trailing twelve month EPS sits a little above US$2.25. Over the last six reported quarters, revenue has ranged from US$8.39 million to US$8.97 million and basic EPS has moved between US$0.42 and US$0.69, setting up a picture where high profitability...

Coya Therapeutics (COYA) has released its FY 2025 results, reporting fourth quarter revenue of US$4.0 million and a basic EPS loss of US$0.34, alongside trailing twelve month revenue of US$7.9 million and a basic EPS loss of US$1.27. The company’s revenue increased from US$0.00 million in the third quarter of 2024 to US$3.6 million in the third quarter of 2025, while quarterly basic EPS has ranged from a loss of US$0.44 in the first quarter of 2025 to a loss of US$0.13 in the third quarter of...

Zomedica (OTCPK:ZOMD.F) has reported its FY 2025 third quarter with total revenue of US$8.1 million and a basic EPS loss of US$0.006, alongside a net loss of US$6.1 million. Over recent quarters, revenue has moved from US$6.1 million in Q2 2024 to US$6.5 million in Q1 2025 and US$8.1 million in Q3 2025, while quarterly net losses have ranged from US$6.1 million to US$63.8 million and trailing twelve month revenue has reached US$29.5 million against a trailing net loss of US$84.5 million. For...

Consolidated Water (CWCO) has put up another solid top line in FY 2025 so far, with Q3 revenue of about US$35.1 million and basic EPS of roughly US$0.35, while the latest trailing twelve months show revenue of about US$130.8 million and EPS of around US$1.09. Over recent periods the company has seen revenue move from roughly US$28.4 million in Q4 2024 to US$35.1 million in Q3 2025, with quarterly EPS shifting from about US$0.11 to US$0.35 over the same stretch. This sets up a story where...

AXT (NasdaqGS:AXTI) reported material insider stock sales by its CEO and a director, alongside an update to revenue guidance. The company lowered revenue expectations after facing reduced export permits for indium phosphide from China. Management continues to emphasize expansion plans and a highly optimistic outlook despite these regulatory and operational challenges. These developments come as AXT trades at $44.36, with the stock showing very large gains of 2,464.2% over the past year and...

The FDA approved an updated label for Krystal Biotech's Vyjuvek (beremagene geperpavec svdt) for epidermolysis bullosa. KB803 progressed as an emerging therapy candidate in Krystal Biotech's pipeline. These developments affect the treatment options available for epidermolysis bullosa and the outlook for NasdaqGS:KRYS. Krystal Biotech, listed on NasdaqGS:KRYS, focuses on gene therapies for rare skin conditions such as epidermolysis bullosa. With Vyjuvek already in the market and KB803 moving...

Napco Security Technologies (NSSC) is back in focus after an exceptional Q4, with revenue growth topping analyst estimates, supported by recurring service revenue and strong demand for its door locking products despite competitive and regulatory pressures. See our latest analysis for Napco Security Technologies. At a share price of $43.59, Napco’s short term share price performance has been relatively muted, with a 90 day share price return of 1.35%. Its 1 year total shareholder return of...

Why Clear Channel Outdoor Holdings Is On Investors’ Radar Clear Channel Outdoor Holdings (CCO) has drawn attention after recent performance data showed a 19% total return over the past 3 months and 110% over the past year, prompting fresh interest in its valuation. See our latest analysis for Clear Channel Outdoor Holdings. At a share price of $2.39, Clear Channel Outdoor Holdings has seen momentum build, with an 18.9% 90 day share price return alongside a 109.7% 1 year total shareholder...

If you are wondering whether BellRing Brands' share price reflects its true worth, this article breaks down what the current market price might be implying about the business. The stock most recently closed at US$18.51, with returns of 8.3% over the past 7 days, 3.6% over 30 days, but a 29.1% decline year to date and a 72.9% decline over the past year. Recent coverage has focused on BellRing Brands as investors react to the sharp 1 year share price decline and the longer term 3 year and 5...

Bumble (BMBL) has wrapped up FY 2025 with fourth quarter revenue of US$224.2 million and a basic EPS loss of US$4.06, alongside a net income loss of US$499.4 million. Over recent periods the company has seen quarterly revenue move from US$261.6 million in Q4 2024 to US$247.1 million in Q1 2025, US$248.2 million in Q2, US$246.2 million in Q3, and US$224.2 million in Q4. EPS swung between a profit of US$0.34 in Q3 and losses such as US$2.45 in Q2 and US$4.06 in Q4, setting up a story that is as...

Summit Midstream (SMC) has reported third quarter FY 2025 revenue of US$138.0 million with a basic EPS loss of US$0.13, as continued losses keep profitability in focus for investors. The company has seen revenue move from US$93.2 million in Q2 FY 2024 to US$138.0 million in Q3 FY 2025, while basic EPS over the same stretch has ranged from a loss of US$19.25 per share in Q3 FY 2024 to a loss of US$0.13 per share in the latest quarter, keeping margins firmly in the red and the quality of the...

Latest FY 2025 earnings snapshot Security National Financial (SNFC.A) closed FY 2025 with fourth quarter revenue of US$83.0 million and basic EPS of US$0.55, alongside trailing 12 month figures of US$344.6 million in revenue and EPS of US$1.30 that sit against earnings growth of 21.2% over the past year. Over recent periods, revenue has moved from US$79.3 million and EPS of effectively zero in Q4 2024 to US$83.0 million and EPS of US$0.55 in Q4 2025. Trailing net income reached US$32.2...

Citi Trends (CTRN) has reported another mixed set of numbers for FY 2026, with third quarter revenue of US$197.1 million, an EPS loss of US$0.86, and a net income loss of US$6.9 million, alongside same store sales growth of 10.8%. Over recent quarters, revenue has moved from US$176.6 million and an EPS loss of US$2.21 in Q2 2025, to US$179.1 million and an EPS loss of US$0.86 in Q3 2025, then to US$201.7 million with EPS of US$0.11 in Q1 2026 and US$190.8 million with EPS of US$0.48 in Q2...

Host Hotels & Resorts has completed the sale of the 444-room Four Seasons Resort Orlando at Walt Disney World Resort and the 125-room Four Seasons Resort and Residences Jackson Hole for US$1.10 billion, realizing an 11.0% unlevered IRR and an EBITDA multiple well above its recent trading level. The transaction marks a major capital recycling move that management says will bolster the balance sheet and expand financial flexibility to pursue higher-return opportunities and future...

A U.S. appeals court recently overturned a US$481 million patent infringement award that Columbia University had previously secured against Gen Digital, sending the case back to a Virginia federal court to reassess whether the cybersecurity-related patents cover abstract ideas. This legal shift meaningfully reduces immediate financial overhang for Gen Digital and could reshape how the company manages intellectual property risk and litigation exposure. We will now explore how this removal of...